Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - May 26th 2025

🤖 Artificial Intelligence and Digital Health Update: WHO Strategy, Cancer…


Onco_background

Oncology Weekly News - May 19th 2025

Latest breakthroughs in oncology research: FDA and EU Approvals, Key Trial Wins…


Onco_background

Oncology Weekly News - May 12th 2025

🧬🚀 Latest breakthroughs in oncology research: Naxitamab, Enhertu, PD-L1, and…


Onco_background

Oncology Weekly News - April 28th 2025

🧬🚀 Oncology Breakthroughs You Can’t Miss: From groundbreaking survival data to…


ELCC 2025_Preview_by_LucidQuest

ELCC 2025 Preview: Key Lung Cancer Highlights to Watch

ELCC 2025 at a glance Looking toward ELCC 2025, LucidQuest highlights…


Onco_background

Oncology Weekly Update - March 10th 2025

🏥Oncology Update: Imfinzi, TEVIMBRA, Taletrectinib & New Trials Welcome to…


AAD 2025 Preview: Key Dermatology Highlights to Watch

AAD 2025 at a glance With AAD 2025 on the horizon, here’s a preview of…


Onco_background

Oncology Weekly Update - March 3rd 2025

Oncology Update: GSK, Enhertu, KEYTRUDA, Cancer Vaccines & More This…


AAAAI 2025 Preview: Key Allergy, Asthma and Immunology Highlights to Watch

AAAAI 2025 at a glance As AAAAI 2025 approaches, LucidQuest highlights…


Onco_background

Oncology Weekly News - February 24th 2025

🏥 Oncology Update: GSK, Enhertu, KEYTRUDA, Cancer Trials & More This…


Onco_background

Oncology Weekly News - February 17th 2025

🏥 Oncology Update: Cancer Trials, Immunotherapy, PADCEV & KEYTRUDA This…


Onco_background

Oncology Weekly News - February 10th 2025

🏥 Oncology Advances: Radium-223, Pembrolizumab, Cabozantinib,…


Privacy Preference Center